BETA

Awaiting committee decision



2014/2133(DEC) 2013 discharge: IMI Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines
Next event: Indicative plenary sitting date, 1st reading/single reading 2015/04/28
RoleCommitteeRapporteurShadows
Lead CONT CZARNECKI Ryszard (ECR) MARINESCU Marian-Jean (EPP), ALIOT Louis (NI), VALLI Marco (EFD)
Opinion ENVI
Opinion ITRE
Lead committee dossier: CONT/8/01601

Activites

  • 2015/04/28 Indicative plenary sitting date, 1st reading/single reading
  • 2015/03/23 Vote in committee, 1st reading/single reading
  • 2014/10/20 Committee referral announced in Parliament, 1st reading/single reading
  • 2014/07/30 Non-legislative basic document published
    • COM(2014)0510 summary
    • DG {'url': 'http://ec.europa.eu/dgs/budget/', 'title': 'Budget'}, GEORGIEVA Kristalina

Documents

AmendmentsDossier
13 2014/2133(DEC)
2015/03/05 CONT 13 amendments...
source: 549.353

History

(these mark the time of scraping, not the official date of the change)

activities/2
date
2015-03-23T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
activities/2
date
2015-03-23T00:00:00
body
EP
type
Vote scheduled in committee, 1st reading/single reading
activities/2/date
Old
2015-03-24T00:00:00
New
2015-03-23T00:00:00
activities/0/commission/0
DG
Commissioner
GEORGIEVA Kristalina
other/0
body
EC
dg
commissioner
GEORGIEVA Kristalina
activities/0/docs/0/text
  • PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2013, as part of the 2013 discharge procedure.

    Analysis of the accounts of the Joint Technology Initiative on Innovative Medicines (IMI).

    CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2013 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU's General Budget, including the IMI Joint Undertaking.

    The document contains the figures on which the discharge procedure is based.

    Discharge procedure of the EU Joint Undertakings: the EU Budget finances a wide range of policies and programmes throughout the EU. In accordance with the priorities set by the European Parliament and the Council in the multi-annual financial framework (MFF), the European Commission carries out specific programmes, activities and projects in the field with the technical support of some specialised agencies.

    The consolidated annual accounts of the EU provide information on the activities of the institutions, agencies and other bodies of the EU from a budgetary and accrual accounting perspective.

    The consolidated reports on the implementation of the general budget of the EU include the budget implementation of all Institutions. Agencies and Joint Undertakings (JUs) do not have a separate budget inside the EU budget; and they are partially financed by a Commission budget subsidy.

    Each JU is subject to its own discharge procedure.

    IMI: in 2013, the tasks and budget of the Joint Undertaking were as follows:

    • description of the tasks of the Joint Undertaking: the IMI Joint undertaking, which is located in Brussels, was set up in 2007 by Council Regulation (EC) No 73/2008 for a period of 10 years. The IMI Joint Undertaking supports pre-competitive pharmaceutical research and development in the Member States and associated countries, aiming at increasing the research investment in the biopharmaceutical sector and promotes the involvement of small and medium-sized enterprises (SME) in its activities;
    • accounts of the JU: the maximum indicative contribution of the Commission to cover running costs and research activities is EUR 1 billion up to 31.12.2017. The cumulative unrecognised share of losses is EUR 16 million.

    Please also consult the final accounts of IMI Joint Undertaking.

activities/1/committees/0/shadows/1
group
EFD
name
VALLI Marco
committees/0/shadows/1
group
EFD
name
VALLI Marco
activities
  • date: 2014-07-30T00:00:00 docs: url: http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2014/0510/COM_COM(2014)0510_FR.pdf celexid: CELEX:52014DC0510:EN type: Non-legislative basic document published title: COM(2014)0510 body: EC type: Non-legislative basic document published commission:
  • date: 2014-10-20T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP shadows: group: EPP name: MARINESCU Marian-Jean group: NI name: ALIOT Louis responsible: True committee: CONT date: 2014-09-26T00:00:00 committee_full: Budgetary Control rapporteur: group: ECR name: CZARNECKI Ryszard body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI body: EP responsible: False committee_full: Industry, Research and Energy committee: ITRE
  • date: 2015-03-24T00:00:00 body: EP type: Vote scheduled in committee, 1st reading/single reading
  • date: 2015-04-28T00:00:00 body: EP type: Indicative plenary sitting date, 1st reading/single reading
committees
  • body: EP shadows: group: EPP name: MARINESCU Marian-Jean group: NI name: ALIOT Louis responsible: True committee: CONT date: 2014-09-26T00:00:00 committee_full: Budgetary Control rapporteur: group: ECR name: CZARNECKI Ryszard
  • body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI
  • body: EP responsible: False committee_full: Industry, Research and Energy committee: ITRE
links
other
    procedure
    dossier_of_the_committee
    CONT/8/01601
    reference
    2014/2133(DEC)
    title
    2013 discharge: IMI Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines
    stage_reached
    Awaiting committee decision
    type
    DEC - Discharge procedure
    subject
    8.70.03.03 2013 discharge